Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients With Inadequately Controlled Type 2 Diabetes on Oral Antidiabetic Drugs in Greece
Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.697
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2014
Authors
Publisher
Elsevier BV